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Abstract
Introduction/Objective—Adults aged 65 or older with arthritis may be at increased risk for 
cognitive impairment [cognitive impairment not dementia (CIND) or dementia]. Studies have 
found associations between arthritis and cognition impairments, however, none have examined 
whether persons with arthritis develop cognitive impairments at higher rates than those without 
arthritis.
Methods—Using data from the Health and Retirement Study (HRS) we estimated the prevalence 
of cognitive impairments in older adults with and without arthritis and examined associations 
between arthritis status and cognitive impairments. We calculated incidence density ratios (IDRs) 
using generalized estimating equations (GEE) to estimate associations between arthritis and 
cognitive impairments adjusting for age, sex, race/ethnicity, marital status, education, income, 
depression, obesity, smoking, chronic conditions, physical activity, and birth cohort.
Results—The prevalence of CIND and dementia did not significantly differ between those with 
and without arthritis (CIND: 20.8%, 95% CI 19.7 – 21.9 vs. 18.3%, 95% CI 16.8 – 19.8; 
dementia: 5.2% 95% CI 4.6 – 5.8 vs. 5.1% 95% CI 4.3 – 5.9). After controlling for covariates, 
older adults with arthritis did not differ significantly from those without arthritis for either 
cognitive outcome (CIND IDR: 1.6, 95% CI = 0.9 – 2.9; dementia IDR: 1.1, 95% CI = 0.4 – 3.3) 
and developed cognitive impairments at a similar rate to those without arthritis.
Conclusion—Older adults with arthritis were not significantly more at risk to develop cognitive 
impairments and developed cognitive impairments at a similar rate as older adults without arthritis 
over six years.
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INTRODUCTION
About half of older adults (≥65 years) have some form of arthritis [1], such as rheumatoid 
arthritis, gout, lupus, or fibromyalgia, and arthritis is a leading cause of disability in U.S. 
adults [2]. While arthritis is known for its debilitating effect on the musculoskeletal system, 
some types of arthritis affect other body systems [3]. Cognitive impairment is also common 
in older adults. In 2010 an estimated 18% of individuals aged 75 to 84 years old and 32% of 
individuals over the age of 85 had Alzheimer disease dementia [4], while 22% of those 71 
years old or older had milder forms of cognitive impairment not dementia (CIND) [5].
Prior studies that have examined associations between arthritis and cognition suggest that 
arthritis may increase the risk for cognitive impairment [6–10]. In one small cross-sectional 
study, 30% of people with rheumatoid arthritis (RA) had cognitive impairment compared to 
7.5% of people without RA [6]. A second small study of 115 people with RA found 
approximately 30% had cognitive impairment [10]. In a larger longitudinal study (n = 
1,449), persons with any joint disorder, but particularly RA, had twice the odds of reporting 
worse cognitive status later in life than those without a joint disorder [8]. A matched nested 
case-control study within a retrospective cohort reported a 25% increase in the incidence of 
dementia among patients with osteoarthritis than among those without osteoarthritis [7]. 
However, another study with the same design and database found no difference in the 
incidence of dementia in people with autoimmune rheumatic diseases compared with those 
without such diseases [9].
A plausible biological mechanism connecting arthritis and cognitive impairment is 
inflammation [11, 12]. Inflammation is common in arthritis. Even osteoarthritis, considered 
a disorder of the hyaline cartilage, is currently viewed as having inflammatory components 
[13]. However, cognitive impairments in people with arthritis may actually result from the 
sequelae of arthritis, rather than the inflammation itself. Cognitive impairment has been 
associated with pain [14], fatigue [15], depression [16] and reduced physical activity [17], 
all important symptoms of arthritis.
The purpose of this study was to describe the prevalence of cognitive impairments in older 
adults with arthritis and to examine the cross-sectional association between arthritis and 
cognitive impairment among older adults after controlling for potential covariates. A 
secondary purpose was to determine if older adults with arthritis developed cognitive 
impairments at a different rate compared with older adults without arthritis. We reasoned 
that those with arthritis would show cognitive impairment before those without arthritis.
MATERIALS AND METHODS
Study Population
The Health and Retirement Study (HRS), started in 1992, is a nationally representative 
longitudinal panel study of U.S. adults over the age of 50 that examines the aging process. 
As a steady-state study, it adds a new cohort of 51 to 56 year olds every 6 years (for a total 
of 5 cohorts by 2010) and obtains data every 2 years. The HRS has been approved by the 
University of Michigan Health Sciences Human Subjects Committee. We analyzed data on 
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adults aged 65 and older from the 2004 cohort through the 2010 cohort (3 waves / 6 years) 
using the RAND Corporation HRS Data File (v. N), which provides self-reported individual 
variables, as well as summarized scores from all HRS waves. A total of 20,129 participants 
in 2004 provided data for the HRS (overall response rate of 87.6% [18]).
Those 65 or older in 2004 were eligible for our study; 9,728 (49%) met this criterion. 
Response rates for these participants for the 2006 to 2010 waves were between 83% and 
89% (Figure 1).
Arthritis Exposure
We identified cases of any type of arthritis with the question: “Have you ever had, or has a 
doctor ever told you that you have arthritis or rheumatism?” A case definition based on a 
similar question has been shown to have moderate specificity [19].
Outcomes
We determined cognitive impairment status using definitions described by Crimmins et al.
[20]. This method included four items for cognitive functioning: a 10-word immediate recall 
test for short-term memory (scored 0–10); a delayed recall test for long-term memory 
(scored 0–10); the serial 7’s subtraction test to assess working memory (scored 0–5); and 
counting backwards from 20 to assess attention and processing speed (scored 0–2). 
Participants were allowed 5 trials for the serial 7’s task, and the backward counting was 
scored as correct/incorrect. Thus, the total cognitive functioning score could range from 0 to 
27. Participants with scores from 0–6 were classified as having dementia, 7–11 as having 
CIND, and 12–27 as having no cognitive impairment [20]. This method of ascertainment has 
moderate specificity [21].
Covariates
Demographic covariates were self-reported age, sex, race/ethnicity, and marital status. Race/
ethnicity was non-Hispanic white, Non-Hispanic black, Hispanic, and Non-Hispanic others 
to protect respondent confidentiality. Marital status was “married/partnered” and “not 
married/partnered”. Socioeconomic covariates were self-reported education (“less than 
college degree” and “college and greater”) and income (from the RAND Corporation 
imputed household income score, coded approximately in thirds [$0 to $19,999; $20,000 to 
$39,999, $40,000 or greater]). Medical characteristic covariates were Body Mass Index 
(BMI) (kg/m2) (dichotomized using standard cutoffs of not obese <30 kg/m2 and obese ≥ 30 
kg/m2), the number of 6 chronic conditions (from doctor-diagnosed conditions: high blood 
pressure, diabetes, cancer, lung disease, heart condition or stroke, categorized as “none”, 
“1”, or “2 or more”), and smoking status (never, previous, current). Depression was assessed 
using a subset of items from the short version of the Center for Epidemiologic Studies 
Depression Scale (CES-D) [22] (categorized as no depression or depression [cutoff of 4 or 
higher]). Physical activity was based on responses to questions about physical activity at 
each of three intensities: 1) vigorous (defined as activities, such as running or jogging, 
swimming, cycling, aerobics or gym workout, tennis, or digging with a spade or shovel), 2) 
moderately energetic (defined as activities such as, gardening, cleaning the car, walking at a 
moderate pace, dancing, floor or stretching exercises), or 3) mildly energetic (defined as 
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activities such as vacuuming, laundry, or home repairs). Although not an official response, 
many participants volunteered “every day”, so that there were five frequency categories. 
Participants who engaged in any intensity physical activity “every day” or “more than once a 
week,” were considered active; “once a week” or “one to three times a month,” somewhat 
active; and “hardly ever or never,” inactive.
Statistical Analysis
We accounted for the complex sample design by including the study design variables (strata 
and sampling units) [23] and baseline weights in all analyses.
We compared characteristics at baseline between those with and without arthritis for each 
type of cognitive impairment status (no cognitive impairment, CIND, and dementia). We 
calculated weighted proportions and 95% confidence intervals (CI) using SAS (v. 9.3 [24]. 
We conservatively defined statistical significance (p ≤ 0.01) in the characteristics using non-
overlapping CIs [25].
To examine associations between arthritis and CIND/dementia, after controlling for potential 
covariates, we calculated incidence density ratios (IDRs) and 95% CI using three modified 
Poisson regression models (i.e. models with robust variance estimators to account for 
variance overestimation due to model-misspecification) with generalized estimating 
equations (GEE) using SUDAAN (v. 11 [26]). Because participants reported outcomes 
multiple times over a six-year follow-up, we used exchangeable correlation matrices to 
account for correlations among these repeated measures. We computed standard errors with 
the Taylor Series Linearization Method (with-replacement sampling) to account for complex 
sample designs. Participants who died, refused to respond, or were lost to follow-up were 
included in the study until their last follow-up. All non-missing pairs of data were used to 
estimate parameters in the correlation matrix [27, 28].
All models were adjusted for age, sex, marital status, education, obesity, smoking, chronic 
conditions, physical activity, and depression. We also adjusted for birth cohort because it is 
independently associated with cognitive impairment [29]. Except for sex, education, race/
ethnicity, and birth cohort, the other covariates were analyzed for changes over follow-up as 
time-dependent covariates (interaction between age and each covariate).
To determine if older adults with arthritis developed cognitive impairments at different rates 
as they aged compared with older adults without arthritis, we calculated the interactions 
between age and arthritis. We also controlled for interactions between age and all the other 
independent variables. A significant interaction effect would suggest that the two groups 
changed at different rates over time.
RESULTS
Of the 9,728 participants, 6,610 (67.9%) reported arthritis. For participants with CIND, a 
significantly higher percentage of participants with arthritis than those without arthritis were 
female, in the lowest income bracket, obese, had two or more chronic conditions, and were 
depressed (Table 1). For participants with dementia, a significantly higher percent of those 
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with arthritis than those without arthritis were female, had two or more chronic conditions, 
and were depressed (Table 1).
CIND crude prevalence for those with arthritis (20.8%, 95% CI 19.7, 21.9) did not differ 
significantly from those without arthritis (18.3%, 95% CI 16.8, 19.8), and the association 
between CIND and arthritis after adjusting for covariates was not significant (CIND IDR: 
1.6, 95% CI = 0.9, 2.9) (Table 2).
Dementia crude prevalence also did not differ significantly between those with arthritis 
(5.2% 95% CI 4.6, 5.8) and those without arthritis (5.1% 95% CI 4.3, 5.9), and the 
association between dementia and arthritis after adjusting for covariates was not significant 
(dementia IDR: 1.1, 95% CI = 0.4, 3.3) (Table 2).
The interaction terms between arthritis and age in the CIND or dementia models were not 
significant (p > .01), indicating that the rate of development of cognitive impairment in older 
adults with arthritis resembled that in those without arthritis.
Although arthritis was not significantly associated with cognitive impairment in our models, 
several covariates were significantly associated with cognitive impairment. Characteristics 
associated with CIND were being male, being either non-Hispanic black or Hispanic, having 
less than a college education, having an income <$40,000, being depressed, and being 
inactive (Table 4). Characteristics specific to dementia resembled those for CIND, except 
that being a male and having less than a college education were not significantly associated 
with dementia, while having 2 or more chronic conditions, never being a smoker, and being 
somewhat inactive were associated with dementia. Of note is the large size of the association 
between those with CIND and those with less than a college education (IDR: 56.5, 95% CI 
20.0, 159.8) and for between those with dementia and non-Hispanic blacks (IDR: 25.4, 95% 
CI 9.0, 71.5), those with incomes <$20,000 (IDR: 45.2 95% CI 7.4, 274.6), and those with 
incomes from $20,000 to $39,999 (IDR: 12.8 95% CI 2.1, 79.6).
DISCUSSION
Despite previous research that reported more cognitive impairment in people with arthritis, 
we found similar percentages of CIND and dementia among older adults with and without 
arthritis over a 6-year period. We also found that older adults with arthritis developed CIND 
or dementia at the same rate as those without arthritis, suggesting that arthritis does not 
accelerate the development of cognitive impairment.
One reason that our study’s results differed from previous studies is our sample selection. 
Ours is the first study to sample from a large representative sample of typically aging adults, 
while previous studies have generally used samples from registries [8], patients in 
rheumatology clinics [6], arthritis-based cohort studies [10], or insurance records [7]. 
Information obtained from these sources may suffer from selection bias, and not represent 
the true population but a group that has severe rather than mild disease. Samples from these 
sources may also receive differential care and more attention than the general population. 
The proposed mechanism for increased cognitive impairment in those with arthritis is 
inflammation. Those who indicated arthritis in our sample probably had a broad spectrum of 
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both arthritis and inflammation from very mild to very severe. This varying degree of 
inflammation may have reduced the ability to detect a relationship between less severe 
arthritis and cognitive impairment. Future studies will need to examine specific types of 
arthritis to define how inflammation and the varying treatments that different types of 
arthritis receive relate to cognitive impairments
Another and perhaps more important reason for the differences in results from our study 
were our evaluation of variables closely associated with both arthritis and cognitive 
impairment. Factors such as pain, fatigue, depression, or reduced physical activity may be 
associated with both arthritis and cognitive impairment. In our study, decreased physical 
activity and depression were strongly associated with CIND or dementia. Although other 
studies adjusted for demographics and comorbidities such as diabetes and COPD, only one 
study [10] adjusted for depression and none for physical activity. Thus, studies that reported 
associations between cognitive impairment and arthritis may have been affected by sequelae 
associated with arthritis.
This study has multiple strengths. Its representativeness enhances its generalizability. Its 
sample size allowed sufficient statistical power to examine multiple associations. Its 
inclusion of relevant covariates allowed for their adjustment. The exclusion of persons with 
baseline cognitive impairment and the subsequent six-year follow-up allowed comparison of 
rates of the development of cognitive impairment. Finally, the use of GEE analytic 
techniques reduces the effects of missing data and accounts for repeated measures [27, 28].
This study has several limitations. First, it did not use objective tests, such as a physician’s 
diagnosis or neurocognitive testing to determine arthritis status or cognitive status. Our 
ascertainment of arthritis using self-report has only moderate specificity (range from 58.8%; 
to 70.6% [19]) and our method of ascertainment of dementia and CIND has a specificity of 
76% [21]. Thus, this study will have misclassified cases of arthritis and cognitive 
impairment, although the prevalence of cognitive impairment resembled that of other studies 
[6, 10]. Second, we did not differentiate between types of arthritis which have varying 
degrees of inflammation, and also varying treatments. It is possible that different types of 
arthritis, such as rheumatoid arthritis, may have a stronger connection with cognitive 
impairments. Third this study excluded study participants who required proxies to provide 
answers, though including proxies did not significantly affect the results. Fourth, the overall 
loss to follow-up was 36%. Fifth, the method of identifying physical activity levels was not 
robust and has not been validated. Sixth, weighting the sample using respondent sampling 
weights from the entry year does not correct for attrition, which may underestimate later 
prevalence estimates. Seventh, the small sample sizes coupled with the potential for 
sampling error for those in subgroups of non-Hispanic Others, those with less than a college 
education, and current smokers indicate that findings for these subgroups should be viewed 
cautiously.
In conclusion, after adjustment for potential confounding variables, arthritis was not 
significantly associated with CIND or dementia among older adults from the general 
population. Moreover, the rate of cognitive decline over the six-year follow-up was similar 
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for those with and without arthritis, suggesting that arthritis does not accelerate the 
development of cognitive impairment in a cohort of typically aging adults.
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Figure 1. 
Flow chart from the complete, eligible Health and Retirement Study 2004 sample to our 
analytic sample of people aged 65 or older.
Lost to Follow-up: Died, non-respondent, or proxy report
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Table 2
Associations between arthritis, demographic characteristics, socioeconomic characteristics, comorbidities, and 
sequelae of arthritis with cognitive impairment, no dementia (CIND) and dementia, Health and Retirement 
Study
CIND Dementia
IDR 95% CL IDR 95% CL
ARTHRITIS (ref: No Arthritis)
 Arthritis 1.6 (0.9, 2.9) 1.1 (0.4, 3.3)
DEMOGRAPHICS
Sex (ref: Male)
 Female 0.3 (0.1, 0.5) 0.6 (0.2, 1.8)
Race (ref: Non-Hispanic white)
 Non-Hispanic Black 14.6 (7.8, 27.3) 25.4 (9.0, 71.5)
 Non-Hispanic Other 4.6 *(0.6, 34.2) 5.7 *(0.2, 146.8)
 Hispanic 11.2 (4.8, 26.0) 8.3 (2.0, 33.7)
Marital Status (ref: Not married/partnered)
 Married/Partnered 0.8 (0.4, 1.5) 0.4 (0.1, 1.2)
SOCIOECONOMIC
Education (ref: College or greater)
 Less than College 56.5 (20.0, 159.8) 7.5 *(0.6, 96.5)
Income (ref: $40,000+)
 $0 to $19,999 10.9 (4.8, 24.8) 45.2 (7.4, 274.6)
 $20,000 to $39,999 4.1 (1.8, 9.1) 12.8 (2.1, 79.6)
MEDICAL CHARACTERISTICS
Obesity (ref: Not obese)
 Obese 1.4 (0.7, 2.5) 1.3 (0.5, 3.6)
Smoking (ref: Never smoked)
 Previous smoker 1.1 (0.6, 2.0) 1.8 (0.6, 5.2)
 Current smoker 1.1 (0.4, 3.0) 0.1 *(0.01, 0.5)
Number of Chronic Conditions (ref: 0 conditions)
 1 condition 0.9 (0.4, 1.8) 0.9 (0.3, 2.7)
 2 or more conditions 1.4 (0.7, 2.7) 4.3 (1.4, 12.9)
OTHER FACTORS
Depression (ref: not depressed)
 Depressed 2.7 (1.6, 4.4) 6.5 (3.0, 14.1)
Physical Activity (ref: Active)
 Inactive 2.2 (1.3, 3.8) 10.3 (4.2, 25.1)
 Somewhat Active 1.2 (0.8, 1.9) 2.2 (1.1, 4.6)
IDR: Incidence Density Ratio; 95% CI: 95% Confidence Interval; ref: reference standard;
*potentially unstable estimate as there is the potential for high sampling error due to small sample size
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